NK-CELL LYMPHOMAS

Clinical trials for NK-CELL LYMPHOMAS explained in plain language.

Never miss a new study

Get alerted when new NK-CELL LYMPHOMAS trials appear

Sign up with your email to follow new studies for NK-CELL LYMPHOMAS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New drug combo tested for Tough-to-Treat blood cancers

Disease control Recruiting now

This early-stage study aims to find a safe and effective dose of two drugs, ruxolitinib and duvelisib, for adults whose T-cell or NK-cell lymphoma has returned or not responded to prior treatments. The main goal is to determine the highest dose patients can tolerate without sever…

Matched conditions: NK-CELL LYMPHOMAS

Phase: PHASE1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control

Last updated Mar 12, 2026 13:51 UTC

NK-CELL LYMPHOMAS

Get alerted when new NK-CELL LYMPHOMAS trials appear

New drug combo tested for Tough-to-Treat blood cancers